DrugPatentWatch Database Preview
Zydus Pharms Company Profile
Try a free trialSee Plans and Pricing
What is the competitive landscape for ZYDUS PHARMS, and what generic alternatives to ZYDUS PHARMS drugs are available?
ZYDUS PHARMS has two hundred and one approved drugs.
There is one US patent protecting ZYDUS PHARMS drugs. There are nine tentative approvals on ZYDUS PHARMS drugs.
There are two patent family members on ZYDUS PHARMS drugs in two countries and three hundred and eight supplementary protection certificates in fifteen countries.
Summary for Zydus Pharms
| International Patents: | 2 |
| US Patents: | 1 |
| Tradenames: | 171 |
| Ingredients: | 169 |
| NDAs: | 201 |
Drugs and US Patents for Zydus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 203553-001 | Nov 16, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 208622-001 | Mar 3, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040596-002 | Nov 18, 2005 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 202456-002 | Feb 13, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078905-002 | Jan 31, 2011 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Zydus Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011089623 | ➤ Sign Up |
| Japan | 2013516459 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Zydus Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1411900 | C01411900/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: ESOMEPRAZOL + NAPROXEN; REGISTRATION NO/DATE: SWISSMEDIC 61330 06.05.2011 |
| 0502314 | C300095 | Netherlands | ➤ Sign Up | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
| 0721777 | 10C0041 | France | ➤ Sign Up | PRODUCT NAME: ATOMOXETINE OPTIONNELLEMENT SOUS FORME D'UN SEL TEL QUE LE CHLORHYDRATE; NAT. REGISTRATION NO/DATE: NL36369 20100628; FIRST REGISTRATION: GB - PL 00006/0374 20040527 |
| 0196222 | SPC/GB01/045 | United Kingdom | ➤ Sign Up | PRODUCT NAME: NATEGLINIDE OR SALTS THEREOF; REGISTERED: CH 55401 20000928; CH 55402 20000928; UK EU/1/01/174/001 20010403; UK EU/1/01/174/002 20010403; UK EU/1/01/174/003 20010403; UK EU/1/01/174/004 20010403; UK EU/1/01/174/005 20010403; UK EU/1/01/174/006 20010403; UK EU/1/01/174/019 20010403; UK EU/1/01/174/020 20010403; UK EU/1/01/174/021 20010403; UK EU/1/01/174/013 20010403; UK EU/1/01/174/014 20010403; UK EU/1/01/174/015 20010403; UK EU/1/01/174/016 20010403; UK EU/1/01/174/017 20010403; UK EU/1/01/174/018 20010403; UK EU/1/01/174/007 20010403; UK EU/1/01/174/008 20010403; UK EU/1/01/174/009 20010403; UK EU/1/01/174/010 20010403; UK EU/1/01/174/011 20010403; UK EU/1/01/174/012 2001040 |
| 1304992 | 2013/044 | Ireland | ➤ Sign Up | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
